Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice
2014
Aims/hypothesis
Apolipoprotein A-I (apoA-I), the main protein constituent of HDL, has a central role in the reverse cholesterol-transport pathway, which together with the anti-inflammatory properties of apoA-I/HDL provide cardioprotection. Recent findings of direct stimulation of glucose uptake in muscle by apoA-I/HDL suggest that altered apoA-I and HDL functionality may be a contributing factor to the development of diabetes. We have studied the in vivo effects of short treatments with human apoA-I in a high-fat diet fed mouse model. In addition to native apoA-I, we investigated the effects of the cardioprotective Milano variant (Arg173Cys).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
40
Citations
NaN
KQI